FDA Approved NSS-2 BRIDGE for Opioid Withdrawal.

FDA Approved NSS-2 BRIDGE for Opioid Withdrawal

On November 15, 2017 U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.

 

Mechanism: 

The NSS-2 BRIDGE is a percutaneous nerve field stimulator (PNFS) device system, that can be used as an aid to reduce the symptoms of opioid withdrawal, through application to branches of Cranial Nerves V, VII, IX, and X, as well as branches of the occipital nerves identified by transillumination. 

Patients can use the device for up to five days during the acute physical withdrawal phase.

It is available only by prescription.

Contraindications:

  1. Hemophilia
  2. Patients with cardiac pacemakers
  3. Psoriasis vulgaris

Source: FDA Press Announcement 

Please do post your questions or comments below. 


Dr. Harvinder Singh, M.D. (Admin)


Enroll in our online course to have access to all important clinically relevant psychiatry topics in one place.


Related Articles